Sign in
4

Changes in Ownership

Ultragenyx Pharmaceutical Inc. Filed Acc 0001209191-23-035692

Director acquired 3,860 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Ray Amrit Director 2023-06-07 Grant or award +3,860 12,280 D
Derivatives
Ray Amrit Director 2023-06-07 Grant or award · Stock Option (Right to Buy) +7,110 7,110 D
Loading xslF345X04/doc4.xml…